Literature DB >> 15071717

Psychopharmacological approaches to modulating attention in the five-choice serial reaction time task: implications for schizophrenia.

Y Chudasama1, T W Robbins.   

Abstract

RATIONALE: In schizophrenia, attentional disturbance is a core feature which may not only accompany the disorder, but may precede the onset of psychiatric symptoms.
OBJECTIVES: The five-choice serial reaction time task (5CSRTT) is a test of visuo-spatial attention that has been used extensively in rats for measuring the effects of systemic and central neurochemical manipulations on various aspects of attentional performance, including selective attention, vigilance and executive control. These findings are relevant to our understanding of the neural systems that may be compromised in patients with schizophrenia.
METHODS: The 5CSRTT is conducted in an operant chamber that has multiple response locations, in which brief visual stimuli can be presented randomly. Performance is maintained using food reinforcers to criterion levels of accuracy. Various aspects of performance are measured, including attentional accuracy and premature responding, especially under different attentional challenges.
RESULTS: The effects of systemic and intra-cerebral infusions of selective dopamine, serotonin and cholinergic receptor agents on the 5CSRTT are reviewed with a view to identifying attention-enhancing effects that may be relevant to the treatment of cognitive deficits in schizophrenia. In addition, some novel agents such as modafinil and histamine receptor agents are also considered. Examining the effects of selective neurochemical lesions helped define the neural locus of attentional effects. Similarly, findings from microdialysis studies helped identify the extracellular changes in neurotransmitters and their metabolites in freely moving rats during performance of the 5CSRTT.
CONCLUSIONS: The monoaminergic and cholinergic systems have independent but complementary roles in attentional function, as measured by the 5CSRTT. These functions are predominantly under the control of the prefrontal cortex and striatum. These conclusions are considered in the context of their application towards therapeutic approaches for attentional disturbances that are typically observed in schizophrenic patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15071717     DOI: 10.1007/s00213-004-1805-y

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  131 in total

1.  Functional disconnection of a prefrontal cortical-dorsal striatal system disrupts choice reaction time performance: implications for attentional function.

Authors:  A Christakou; T W Robbins; B J Everitt
Journal:  Behav Neurosci       Date:  2001-08       Impact factor: 1.912

Review 2.  Catecholamine regulation of the prefrontal cortex.

Authors:  A F Arnsten
Journal:  J Psychopharmacol       Date:  1997       Impact factor: 4.153

3.  Modafinil: an antinarcoleptic drug with a different neurochemical profile to d-amphetamine and dopamine uptake blockers.

Authors:  L Ferraro; T Antonelli; W T O'Connor; S Tanganelli; F A Rambert; K Fuxe
Journal:  Biol Psychiatry       Date:  1997-12-15       Impact factor: 13.382

4.  Immunolesioning: selective destruction of neurons using immunotoxin to rat NGF receptor.

Authors:  R G Wiley; T N Oeltmann; D A Lappi
Journal:  Brain Res       Date:  1991-10-18       Impact factor: 3.252

5.  A common action of clozapine, haloperidol, and remoxipride on D1- and D2-dopaminergic receptors in the primate cerebral cortex.

Authors:  M S Lidow; P S Goldman-Rakic
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

6.  Acute behavioral and physiological effects of modafinil in drug abusers.

Authors:  C R Rush; T H Kelly; L R Hays; R W Baker; A F Wooten
Journal:  Behav Pharmacol       Date:  2002-03       Impact factor: 2.293

7.  Distinct changes in cortical acetylcholine and noradrenaline efflux during contingent and noncontingent performance of a visual attentional task.

Authors:  J W Dalley; J McGaughy; M T O'Connell; R N Cardinal; L Levita; T W Robbins
Journal:  J Neurosci       Date:  2001-07-01       Impact factor: 6.167

8.  Activation of 5-HT2A receptors impairs response control of rats in a five-choice serial reaction time task.

Authors:  T Koskinen; S Ruotsalainen; T Puumala; R Lappalainen; E Koivisto; P T Männistö; J Sirviö
Journal:  Neuropharmacology       Date:  2000-01-28       Impact factor: 5.250

9.  Involvement of the prefrontal cortex but not the dorsal hippocampus in the attention-enhancing effects of nicotine in rats.

Authors:  Britta Hahn; Mohammed Shoaib; Ian P Stolerman
Journal:  Psychopharmacology (Berl)       Date:  2003-04-16       Impact factor: 4.530

10.  Behavioral vigilance in rats: task validation and effects of age, amphetamine, and benzodiazepine receptor ligands.

Authors:  J McGaughy; M Sarter
Journal:  Psychopharmacology (Berl)       Date:  1995-02       Impact factor: 4.530

View more
  46 in total

Review 1.  CNTRICS final animal model task selection: control of attention.

Authors:  C Lustig; R Kozak; M Sarter; J W Young; T W Robbins
Journal:  Neurosci Biobehav Rev       Date:  2012-06-06       Impact factor: 8.989

Review 2.  Schizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits.

Authors:  Manoranjan S D'Souza; Athina Markou
Journal:  Neuropharmacology       Date:  2011-02-01       Impact factor: 5.250

Review 3.  Schizophrenia-relevant behavioral testing in rodent models: a uniquely human disorder?

Authors:  Craig M Powell; Tsuyoshi Miyakawa
Journal:  Biol Psychiatry       Date:  2006-06-15       Impact factor: 13.382

Review 4.  Assessing behavioural and cognitive domains of autism spectrum disorders in rodents: current status and future perspectives.

Authors:  Martien J Kas; Jeffrey C Glennon; Jan Buitelaar; Elodie Ey; Barbara Biemans; Jacqueline Crawley; Robert H Ring; Clara Lajonchere; Frederic Esclassan; John Talpos; Lucas P J J Noldus; J Peter H Burbach; Thomas Steckler
Journal:  Psychopharmacology (Berl)       Date:  2013-09-19       Impact factor: 4.530

5.  Dopamine D1 receptor activation improves PCP-induced performance disruption in the 5C-CPT by reducing inappropriate responding.

Authors:  S A Barnes; J W Young; S T Bate; J C Neill
Journal:  Behav Brain Res       Date:  2015-11-30       Impact factor: 3.332

Review 6.  Advances in understanding mechanisms of thalamic relays in cognition and behavior.

Authors:  Anna S Mitchell; S Murray Sherman; Marc A Sommer; Robert G Mair; Robert P Vertes; Yogita Chudasama
Journal:  J Neurosci       Date:  2014-11-12       Impact factor: 6.167

Review 7.  The NEWMEDS rodent touchscreen test battery for cognition relevant to schizophrenia.

Authors:  M Hvoslef-Eide; A C Mar; S R O Nilsson; J Alsiö; C J Heath; L M Saksida; T W Robbins; T J Bussey
Journal:  Psychopharmacology (Berl)       Date:  2015-07-24       Impact factor: 4.530

Review 8.  Translating the Habenula-From Rodents to Humans.

Authors:  Laura-Joy Boulos; Emmanuel Darcq; Brigitte Lina Kieffer
Journal:  Biol Psychiatry       Date:  2016-06-07       Impact factor: 13.382

9.  The 5-choice continuous performance test: evidence for a translational test of vigilance for mice.

Authors:  Jared W Young; Gregory A Light; Hugh M Marston; Richard Sharp; Mark A Geyer
Journal:  PLoS One       Date:  2009-01-19       Impact factor: 3.240

10.  Disruption of mesolimbic regulation of prefrontal cholinergic transmission in an animal model of schizophrenia and normalization by chronic clozapine treatment.

Authors:  Kathleen S Alexander; Julie M Brooks; Martin Sarter; John P Bruno
Journal:  Neuropsychopharmacology       Date:  2009-08-19       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.